drugset / Trial / NCT01290042
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
RandomizedSingle-groupQuadruple-blindTreatment
Summary
To assess the safety and tolerability of multiple subcutaneous doses of AMG 181 in healthy subjects, in subjects with active ulcerative colitis, and in subjects with active Crohn's disease.
Timeline
- Start
- 2011-02
- Primary completion
- 2014-04
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abrilumab | Monoclonal antibody | — | Subcutaneous |